Every weekday, the Investing Club releases the Homestretch; an actionable afternoon update just in time for the last hour of…
Dont assume that because Berkshire is worth nearly $900 billion, its sure to get to $1 trillion first.…
Dont assume that because Berkshire is worth nearly $900 billion, its sure to get to $1 trillion first.…
Shares of Eli Lilly and Regeneron are both well into the range where splits would make sense.…
Experts told Forbes incumbents Novo Nordisk and Eli Lilly are unlikely to cede much ground to rival weight loss drugs…
All three of these high-flying stocks could have more room to run.…
All three of these high-flying stocks could have more room to run.…
…
Novo Nordisk and Eli Lilly dominate the weight-loss market, but progress from a rising biotech could spell trouble for the…
…
Novo Nordisk and Eli Lilly dominate the weight-loss market, but progress from a rising biotech could spell trouble for the…
…
Eli Lilly just partnered with Amazon to help accelerate distribution of its various treatments.…
Eli Lilly , Novo Nordisk shares slide after CBO comments on obesity drugs…
A recent FDA announcement may have just put one company in the lead.…
Heres what could happen to Eli Lilly shares next.…
Free two-day shipping for Prime members and a direct-to-consumer sales model could accelerate sales of Eli Lillys Zepbound.…
Free two-day shipping for Prime members and a direct-to-consumer sales model could accelerate sales of Eli Lillys Zepbound.…
The drugmaker is caught up in an unexpected situation with regulators.…
…
The companys valuation may be high but that doesnt mean Eli Lilly is anywhere near its peak.…
The companys valuation may be high but that doesnt mean Eli Lilly is anywhere near its peak.…
Here are Fridays biggest calls on Wall Street.…
Viking Therapeutics just might be an attractive acquisition target for Pfizer.…
Viking Therapeutics just might be an attractive acquisition target for Pfizer.…
…
There are good reasons to remain optimistic.…
Eli Lilly (LLY) partners with Amazon Pharmacy to help deliver its obesity, migraine and diabetes drugs, including Zepbound.…
U.S. stocks are little changed early Wednesday, one day after a strong rally sent to the S&P 500 to a…
Ozempic maker Novo Nordisk and Mounjaro maker Eli Lilly dominate the lucrative weight loss drug market with Wegovy and Zepbound,…
Amazon Pharmacy second online pharmacy to partner with Eli Lillys site, and could provide faster deliveries for certain patients.…
"Bloomberg Markets" follows the market moves across every global asset class and discusses the biggest issues for Wall Street. Guests…
A relatively tiny company ($508 million market cap) that most investors have never heard of has been doling out a…
…
Thanks to exchange-traded funds (ETFs), investors don’t have to be tied to one specific stock. Biotech ETFs allow market participants…
Here are Mondays biggest calls on Wall Street.…
…
The FDA decision on Eli Lillys (LLY) Alzheimers candidate, donanemab, was expected in the first quarter of 2024, which has…
…
Viking Therapeutics has a promising anti-obesity treatment that is generating a lot of interest.…
…
Good news could be in store for all three of these drugmakers.…
Lillys recently approved weight-loss drug is off to a good start.…
These are the stocks posting the largest moves in midday trading.…
The FDA decision delay is surprising and disappointing, Jim Cramer said Friday. But its not a thesis-shattering event.…
The FDA plans to call a last-minute meeting of its outside advisors to further review the Eli Lilly Alzheimers treatments…
INDIANAPOLS (dpa-AFX) - Der US-Arzneimittelhersteller Lilly muss womöglich noch länger auf eine Zulassung seines Alzheimermittels…
FDA to review Eli Lillys Alzheimers drug donanemab…
Cignas Evernorth struck agreements with Novo Nordisk and Eli Lilly to limit spending increases for those GLP-1s to a maximum…
Novo Nordisk shares climbed 5% on Thursday morning after the Danish pharmaceutical giant reported positive early trial data for a…